Phase I trial of interferon α2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Interferon-alpha
  • Kidney Neoplasms
  • Tretinoin

abstract

  • The acceptable toxicity profile and preliminary efficacy results suggest that this regimen warrants further evaluation. ATRA-IV (15 mg/m(2) TIW) and interferon-alpha (3 MU Monday through Friday escalated weekly to 5 MU and to 7 MU) are recommended for further study in patients with advanced RC.

publication date

  • September 15, 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.10809

PubMed ID

  • 12216088

Additional Document Info

start page

  • 1220

end page

  • 7

volume

  • 95

number

  • 6